Ipsos Revises 2026 Organic Growth Outlook to 1.2%-1.5%
Bitget2026/10/23 05:50- Ipsos revised its full-year 2026 organic growth outlook to 1.2%-1.5%, versus 0.6% in 2025.
- The operating margin target remains unchanged, in line with 2025.
- The revised outlook reflects nine-month performance, September’s order book and persistent macroeconomic and geopolitical uncertainty, including the Middle East conflict.
- Nine-month organic growth reached 1.2%; revenue rose 0.9% to €1.81 billion.
- Third-quarter organic growth accelerated to 2% from 0.8% in the first half.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Updated version 2-BP reports the highest net profit in at least five years
AstraZeneca (AZN.US) Q3 profit growth surpasses expectations, driven mainly by oncology drugs
AstraZeneca (AZN.US) released its Q3 2026 results on October 30th. At constant exchange rates (CER), total revenue for the quarter increased by 7% year-on-year to $16.209 billions.
BP.US Q3 profits soar to 18-year high: Refining business becomes 'money-printing machine', CEO's reforms encounter strong tailwind
Benefiting from a surge in refining profit margins, BP's quarterly profit jumped to its highest level in 18 years.
Australian Dollar: Bias shifts back to neutral against US Dollar – UOB
Crypto prices
More
